| Rising tide of vaccinations lifts all assets as optimism grows for 2021 Coronavirus vaccinations are fast becoming a reality, as the UK prepares for the rollout of a recently approved Covid-19 shot from Pfizer and Germany’s BioNTech next week. UK Health Secretary Matt Hancock has described the oncoming vaccination programme as “one of the biggest civilian logistical efforts that we’ve faced as a nation”. The rest of the world is not far behind, as 100,000 people are currently hospitalised with Covid-19 in the US, and President Donald Trump is said to be “livid” that the US was not the first country to approve the Pfizer vaccine. American health experts have accused British regulators of not examining the vaccine data carefully enough. With Moderna and AstraZeneca also returning positive trial data for their vaccines, many are hopeful that next year could bring a return to pre-pandemic normality, putting economic growth and international travel back on the map. Meanwhile, global markets have surged, lifting everything from airlines and hotel groups to junk bonds and bitcoin. Out-of-favour value stocks have shot up, prompting some managers to hope for a sustained rotation out of growth and into value investing as the economy recovers. Emerging markets look set to be another beneficiary of investors’ rosy outlook, as the favourite asset class for 50 per cent of fund managers going into 2021. However, Eaton Vance warns that the countries classed as emerging markets are not a monolith, and will diverge sharply in the post-pandemic environment. However, the world’s mounting debt pile – already USD15 trillion greater than it was at the start of the year – and a degree of uncertainty over the success of a vaccine at containing the pandemic are making some asset managers nervous. Investors could be at risk of being swept up in short-term volatility and market shake-ups, and Fidelity International’s CIO warned recently of his concerns that “this optimism will not always be matched by the economic reality of 2021”. Instead, regulators say it is time to think about long-term reform. The pandemic has been a wake-up call on a par with the global financial crisis in 2008, say policy-makers, setting their sights on reforming money market funds. This has kicked off an argument in the money market industry over their role in March’s turmoil.
Madeleine Taylor Editor, Institutional Asset Manager [email protected]
| ADVERTISEMENT | | | | | | | | | | | | CACEIS appoints head of UK business | Fri | 4 Dec 2020, 11:49 | CACEIS, a European securities, depository and administration specialist to the pensions and asset management industry, has appointed Pat Sharman as head of the UK business following the cross-border merger of KAS BANK into CACEIS Bank, which took effect on 1 November 2020. |
| | ADVERTISEMENT | | | BTIG adds Director in Research & Strategy division | Fri | 4 Dec 2020, 11:49 | BTIG has hired Timothy Hayes as a Director within its Research and Strategy division. Hayes joins the continued expansion of BTIG’s Financials Research team as an analyst focused on commercial mortgage and specialty finance. He will be based in New York and report into David Lenchus, Director of Research, at BTIG. |
| | Growth of parallel funds in the face of EU complexity | Fri | 4 Dec 2020, 11:49 | Luxembourg remains a key hub of fund distribution. However, the complexity of the European regulation has seen a rise in managers setting up more parallel funds in other jurisdictions. This is done to accommodate non-EU investors, who may struggle with the demands of the EU fund regulations. |
| | | | | | | ADVERTISEMENT | | | | Copyright © 2020 All Rights Reservered About | Disclaimer Unsubscribe me from the list | |
|